These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21121812)

  • 41. Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation.
    Binder H; Strick R; Zaherdoust O; Dittrich R; Hamori M; Beckmann MW; Oppelt PG
    Fertil Steril; 2012 May; 97(5):1169-75.e1. PubMed ID: 22401810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility.
    Yang CQ; Chan KY; Ngan HY; Khoo US; Chiu PM; Chan QK; Xue WC; Cheung AN
    Carcinogenesis; 2006 Jul; 27(7):1502-6. PubMed ID: 16574671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone.
    de Castro F; Ruiz R; Montoro L; Pérez-Hernández D; Sánchez-Casas Padilla E; Real LM; Ruiz A
    Fertil Steril; 2003 Sep; 80(3):571-6. PubMed ID: 12969700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FSH: urinary and recombinant.
    Palagiano A; Nesti E; Pace L
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115 Suppl 1():S30-3. PubMed ID: 15196713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
    Huber M; Hadziosmanovic N; Berglund L; Holte J
    Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The follicle-stimulating hormone receptor Asn680Ser polymorphism is associated with preterm birth in Hispanic women.
    Dominguez-Lopez P; Diaz-Cueto L; Arechavaleta-Velasco M; Caldiño-Soto F; Ulloa-Aguirre A; Arechavaleta-Velasco F
    J Matern Fetal Neonatal Med; 2018 Mar; 31(5):580-585. PubMed ID: 28282771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene.
    Lussiana C; Guani B; Mari C; Restagno G; Massobrio M; Revelli A
    Obstet Gynecol Surv; 2008 Dec; 63(12):785-95. PubMed ID: 19017414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A distribution of two SNPs in exon 10 of the FSHR gene among the women with a diminished ovarian reserve in Ukraine.
    Livshyts G; Podlesnaja S; Kravchenko S; Sudoma I; Livshits L
    J Assist Reprod Genet; 2009 Jan; 26(1):29-34. PubMed ID: 19031050
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sequential low-dose step-up and step-down protocols with recombinant follicle-stimulating hormone in polycystic ovary syndrome: prospective comparison with step-down protocol.
    Casadei L; Puca F; Emidi E; Manicuti C; Madrigale A; Piccione E
    Arch Gynecol Obstet; 2012 Nov; 286(5):1291-7. PubMed ID: 22729136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clomiphene citrate resistance in relation to follicle-stimulating hormone receptor Ser680Ser-polymorphism in polycystic ovary syndrome.
    Overbeek A; Kuijper EA; Hendriks ML; Blankenstein MA; Ketel IJ; Twisk JW; Hompes PG; Homburg R; Lambalk CB
    Hum Reprod; 2009 Aug; 24(8):2007-13. PubMed ID: 19401323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?].
    Grzegorczyk-Martin V; Khrouf M; Bringer-Deutsch S; Mayenga JM; Kulski O; Cohen-Bacrie P; Benaim JL; Belaisch-Allart J
    Gynecol Obstet Fertil; 2012; 40(7-8):411-8. PubMed ID: 22521986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlled ovarian hyperstimulation pharmacogenetics: a simplified model to genetically dissect estrogen-related diseases.
    Morón FJ; Galán JJ; Ruiz A
    Pharmacogenomics; 2007 Jul; 8(7):775-85. PubMed ID: 17638514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
    Manzanares MA; Gómez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2010 Mar; 93(4):1215-9. PubMed ID: 19200978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter.
    Ferlin A; Vinanzi C; Selice R; Garolla A; Frigo AC; Foresta C
    Fertil Steril; 2011 Dec; 96(6):1344-1349.e2. PubMed ID: 22000911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacogenomics in IVF: A New Era in the Concept of Personalized Medicine.
    Kalinderi K; Asimakopoulos B; Nikolettos N; Manolopoulos VG
    Reprod Sci; 2019 Oct; 26(10):1313-1325. PubMed ID: 29587614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re: Treatment with Human, Recombinant FSH Improves Sperm DNA Fragmentation in Idiopathic Infertile Men Depending on the FSH Receptor Polymorphism p.N680S: A Pharmacogenetic Study.
    Niederberger C
    J Urol; 2017 Jun; 197(6):1537-1538. PubMed ID: 28505940
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacogenetics of FSH Action in the Male.
    Schubert M; Pérez Lanuza L; Gromoll J
    Front Endocrinol (Lausanne); 2019; 10():47. PubMed ID: 30873114
    [TBL] [Abstract][Full Text] [Related]  

  • 59. There is no complete linkage between the polymorphisms N680S and T307A of the follicular stimulating hormone receptor gene in fertile women.
    Rodini GP; Genro VK; Matte U; Pereira FS; Bilibio JP; Greggianin C; Souza CA; Cunha-Filho JS
    J Assist Reprod Genet; 2011 Mar; 28(3):221-4. PubMed ID: 21063764
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic techniques for pharmacogenetic analyses.
    van der Straaten T; van Schaik RH
    Curr Pharm Des; 2010; 16(2):231-7. PubMed ID: 20214624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.